Rheumatology

Bringing hope with new therapies

Patients with rheumatic disease often deal with chronic conditions impacting daily activities. The need for new therapies is high. Each clinical trial brings hope of effective disease management. Our experienced team is here to support.

Rheumatology Expertise

  • Board-certified rheumatologists (adult and pediatric)
  • Operational strategy and execution experts, onnovating to enhance recruitment and data quality for new therapies
  • Conducted over 320 rheumatology trials since 2011, for lupus, rheumatoid arthritis, osteoarthritis, and other rare rheumatic diseases
  • 100% of the rheumatology drugs developed from 2016-2023 involved our expertise, including those for rheumatoid arthritis and osteoporosis

Transform your Rheumatology trials

Rheumatology clinical trials face challenges from low patient recruitment to high placebo response rates and complex endpoint data. With the power of IQVIA Connected Intelligence, we put therapeutic expertise, innovation and actionable insights into rheumatology solutions to increase predictability and speed. This approach helps you meet milestones faster to bring new therapies to waiting patients.

ARTICLE
Disruptive Factors Shape RA Landscape
As the range of treatment options for rheumatoid arthritis (RA) continues to grow and biosimilars are poised to enter the arena, the need for expert strategies to improve therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.

Solutions you may be interested in

Contact Us